BR9906350A - Composição contendo cetanserina e l-carnitina ou uma alcanoil l-carnitina para o tratamento de crps - Google Patents

Composição contendo cetanserina e l-carnitina ou uma alcanoil l-carnitina para o tratamento de crps

Info

Publication number
BR9906350A
BR9906350A BR9906350-6A BR9906350A BR9906350A BR 9906350 A BR9906350 A BR 9906350A BR 9906350 A BR9906350 A BR 9906350A BR 9906350 A BR9906350 A BR 9906350A
Authority
BR
Brazil
Prior art keywords
carnitine
crps
ketanserin
alkanoyl
treatment
Prior art date
Application number
BR9906350-6A
Other languages
English (en)
Inventor
Claudio Cavazza
Menotti Calvani
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of BR9906350A publication Critical patent/BR9906350A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçãO CONTENDO CETANSERINA E L-CARNITINA OU UMA ALCANOIL L-CARNITINA PARA O TRATAMENTO DE CRPS"<D>. Uso de cetanserina em combinação com L-carnitina, algumas alcanoil L-carnitinas e os sais farmacologicamente aceitáveis das mesmas é divulgado para o tratamento de CRPS.
BR9906350-6A 1998-04-10 1999-04-08 Composição contendo cetanserina e l-carnitina ou uma alcanoil l-carnitina para o tratamento de crps BR9906350A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI000774A IT1299069B1 (it) 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")
PCT/IT1999/000084 WO1999052517A2 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps

Publications (1)

Publication Number Publication Date
BR9906350A true BR9906350A (pt) 2000-09-19

Family

ID=11379743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9906350-6A BR9906350A (pt) 1998-04-10 1999-04-08 Composição contendo cetanserina e l-carnitina ou uma alcanoil l-carnitina para o tratamento de crps

Country Status (17)

Country Link
US (2) US6214884B1 (pt)
EP (1) EP0994703B1 (pt)
JP (1) JP4482163B2 (pt)
KR (1) KR100573010B1 (pt)
AT (1) ATE244566T1 (pt)
AU (1) AU742013B2 (pt)
BR (1) BR9906350A (pt)
CA (1) CA2292638C (pt)
DE (1) DE69909395T2 (pt)
DK (1) DK0994703T3 (pt)
ES (1) ES2203115T3 (pt)
HK (1) HK1026608A1 (pt)
IL (1) IL133141A (pt)
IT (1) IT1299069B1 (pt)
NZ (1) NZ501416A (pt)
PT (1) PT994703E (pt)
WO (1) WO1999052517A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084905A2 (en) * 2003-03-24 2004-10-07 University Of Florida Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN1686139B (zh) * 2005-04-30 2012-07-11 福建师范大学 酮色林在治疗炎性疼痛的新型镇痛药中的应用
KR20240100931A (ko) 2022-12-23 2024-07-02 주식회사 일리아스바이오로직스 슈퍼-리프레서(super-repressor, SR)-IκB(srIκB)를 포함하는 엑소좀의 복합부위통증증후군에 대한 치료적 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism

Also Published As

Publication number Publication date
KR20010013685A (ko) 2001-02-26
EP0994703A2 (en) 2000-04-26
HK1026608A1 (en) 2000-12-22
CA2292638C (en) 2008-08-26
AU3442699A (en) 1999-11-01
CA2292638A1 (en) 1999-10-21
KR100573010B1 (ko) 2006-04-24
DE69909395T2 (de) 2004-06-09
PT994703E (pt) 2003-11-28
WO1999052517A2 (en) 1999-10-21
IL133141A0 (en) 2001-03-19
NZ501416A (en) 2002-03-01
AU742013B2 (en) 2001-12-13
WO1999052517A3 (en) 2000-01-06
US6214884B1 (en) 2001-04-10
IL133141A (en) 2006-06-11
DK0994703T3 (da) 2003-11-03
JP4482163B2 (ja) 2010-06-16
IT1299069B1 (it) 2000-02-07
EP0994703B1 (en) 2003-07-09
JP2002504934A (ja) 2002-02-12
DE69909395D1 (de) 2003-08-14
US20040209906A1 (en) 2004-10-21
ES2203115T3 (es) 2004-04-01
ATE244566T1 (de) 2003-07-15
ITMI980774A1 (it) 1999-10-10

Similar Documents

Publication Publication Date Title
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
CA2322311A1 (en) Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
BR0014078A (pt) Inibidores de fator xa
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
ATE320436T1 (de) Dimere pyrrolobenzodiazepine
ATE231872T1 (de) Thiazolopyrimidinderivate
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
RS49795B (sr) Sredstva sa antidepresivnim dejstvom
BR9403783A (pt) Uso de uma composição cosmética
IL129592A0 (en) 5-HT1f agonists
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
DK0736525T3 (da) Benzonitriler som 5-HT-agonister og -antagonister
AR016981A2 (es) Polipeptidos sinteticos
TR199900505T2 (pt)
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
EE05211B1 (et) Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks
BR9906350A (pt) Composição contendo cetanserina e l-carnitina ou uma alcanoil l-carnitina para o tratamento de crps
NO20033184L (no) Anvendelse av forbindelsen (+)-&lt;alfa&gt;-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol
BR9811643A (pt) Suplementação quìmica de osso
ITRM980238A0 (it) Composizione comprendente l -carnitina o un&#39;alcanoil l-carnitina e nadh e/o nadph
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida
BR9713514A (pt) Novo uso de creatina
DE69901805D1 (de) Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin
ES2196769T3 (es) Uso topico de loperamide para el tratamiento de infecciones microbianas.
NZ500533A (en) Osteoblast-promoting pharmaceutical composition comprising an alkanoyl L-carnitine compound and DHEA or DHEA-S

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT. CL.: A61K 31/495; A61P 25/02; C07D 403/06.

Ipc: A61K 31/495 (2008.04), A61P 25/02 (2008.04), C07D

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.